![David Gilman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Gilman
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von David Gilman
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 15 | |
Clearview Healthcare Partners LLC
![]() Clearview Healthcare Partners LLC Miscellaneous Commercial ServicesCommercial Services Clearview Healthcare Partners LLC is a consulting firm serving the life science sector. Its services includes pharma, biotech, medtech, diagnostics, advanced analytics, pricing and market access. The company was founded in 2007 and is headquartered in Boston, MA.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Novartis Oncology, Inc.
![]() Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von David Gilman
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
CELGENE | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Comptroller/Controller/Auditor Corporate Officer/Principal | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
ADC Products (UK) Ltd.
![]() ADC Products (UK) Ltd. Medical/Nursing ServicesHealth Services ADC Products (UK) Ltd. operates as a clinical stage biotechnology company. It develops pyrrolobenzodiazepines for antibody-drug conjugation. The company was founded in November 2000 and is headquartered in Reading, the United Kingdom. | Medical/Nursing Services | Founder Director/Board Member Director/Board Member | |
ADC Therapeutics (UK) Ltd.
![]() ADC Therapeutics (UK) Ltd. BiotechnologyHealth Technology Part of ADC Therapeutics SA, ADC Therapeutics (UK) Ltd. is a British company that provides research and experimental development in biotechnology. The company is based in Reading, UK and was founded in 2014. | Biotechnology | Director/Board Member Director/Board Member | |
NOVARTIS AG | Pharmaceuticals: Major | Investor Relations Contact Corporate Officer/Principal | |
Spirogen SARL
![]() Spirogen SARL Pharmaceuticals: MajorHealth Technology Spirogen SARL is a Swiss company. 'The private company is based in Lausanne, Switzerland. The company was founded by Christopher John Martin. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Centocor, Inc.
![]() Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Auven Therapeutics Management LLLP
![]() Auven Therapeutics Management LLLP Investment ManagersFinance Founded in 2007 by Stephen Evans-Freke and Peter Corr, Auven Therapeutics Management LLLP is a global private equity firm located in St. Thomas, Virgin Islands. They also have operations in New York City and Europe. The firm was formerly known as Celtic Therapeutics Management, which was the successor firm to Celtic Pharma Management LP. | Investment Managers | Founder Private Equity Investor | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
University of Pennsylvania | College/University | Undergraduate Degree Doctorate Degree | |
RUBIUS THERAPEUTICS | Biotechnology | Director/Board Member Director of Finance/CFO | |
Auven Therapeutics Holdings LP
![]() Auven Therapeutics Holdings LP Investment ManagersFinance Auven Therapeutics Holdings LP invests in late stage companies developing therapeutic products (small-molecules & biologics) and related diagnostics. It provides financing for buyouts and late stage capital requirements. It makes controlling investments. | Investment Managers | Founder Chief Executive Officer | |
IMMUNOGEN, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Aventis, Inc. | Chief Tech/Sci/R&D Officer | ||
Synergie Lyon Cancer
![]() Synergie Lyon Cancer Miscellaneous Commercial ServicesCommercial Services Synergie Lyon Cancer provides health care services. It focuses on research efforts on cancer escape, apoptosis and senescence and Immune surveillance. The company was founded in 2007 and is headquartered in Lyon, France. | Miscellaneous Commercial Services | President | |
Oxford BioTherapeutics Ltd.
![]() Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
COMPUGEN LTD. | Biotechnology | Director/Board Member | |
E-Z-EM, Inc.
![]() E-Z-EM, Inc. Medical SpecialtiesHealth Technology E-Z-EM, Inc. develops, manufactures and markets diagnostic imaging products. The firm's products are used for computed tomography and magnetic resonance imaging, colorectal cancer screening, evaluation of swallowing disorders and testing for other diseases, and disorders of the gastrointestinal system. The company was founded in 1961 and is headquartered in Lake Success, NY. | Medical Specialties | Human Resources Officer | |
International Drug Development Institute SA
![]() International Drug Development Institute SA Miscellaneous Commercial ServicesCommercial Services International Drug Development Institute SA engages in the provision of biostatistics and electronical-clinical solutions for phase I-IV clinical trials. It offers oncology clinical research, consultancy, clinical data management, data standards implementation and randomization services. The company was founded by Marc Buyse in 1991 and is headquartered in Louvain-la-Neuve, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
iTeos Therapeutics SA
![]() iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
NETRIS Pharma SAS
![]() NETRIS Pharma SAS BiotechnologyHealth Technology NETRIS Pharma SAS develops targeted therapies for the treatment of cancer. The company is based in Lyon, France. The French company was founded in 2008 by Patrick Mehlen, Agnès Bernet. Patrick Mehlen has been the CEO since 2008. | Biotechnology | Chairman | |
APREA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
ADVANCED ACCELERATOR APPLICATION SA(ADR) | Medical Specialties | Chairman | |
CIBA Vision GmbH (Germany)
![]() CIBA Vision GmbH (Germany) Electronic ComponentsElectronic Technology Part of Alcon AG, CIBA Vision GmbH is a company based in Grosswallstadt, Germany. CIBA Vision GmbH manufactures and markets contact lenses. The German company was founded in 1983. The CEO is Norbert Dörr. | Electronic Components | Director/Board Member | |
ENDOCYTE, INC. | Pharmaceuticals: Major | Director/Board Member | |
Friedrich-Alexander University of Erlangen-Nuremberg | College/University | Doctorate Degree | |
INCYTE CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
GALAPAGOS NV | Biotechnology | Director/Board Member | |
Novo Holdings AS (Denmark)
![]() Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Director/Board Member | |
Artbio, Inc.
![]() Artbio, Inc. Hospital/Nursing ManagementHealth Services Artbio, Inc. is a company that is focused on redefining cancer care by developing a new class of alpha radioligand therapies (ART) and building an ecosystem that maximizes their potential. Artbio is based in Cambridge, MA and has subsidiaries in Norway. The company puts the patient at the core of everything they do. The company was founded in 2021 by Emanuele Ostuni, Roy Hartvig Larsen, and Øyvind Sverre Bruland. Emanuele Ostuni has been the CEO since 2021. | Hospital/Nursing Management | Director/Board Member | |
Rhone Poulenc Rorer
![]() Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Chemicals: Specialty | Corporate Officer/Principal | |
Institut de Recherches Internationales Servier
![]() Institut de Recherches Internationales Servier Miscellaneous Commercial ServicesCommercial Services Part of Servier SAS, Institut de Recherches Internationales Servier is a French company that provides scientific research and development services. The company is based in Suresnes, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Sanofi-Aventis Pharmaceuticals | Corporate Officer/Principal | ||
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Georgia | College/University | Doctorate Degree | |
University of Massachusetts | College/University | Undergraduate Degree | |
The United States Pharmacopeia
![]() The United States Pharmacopeia Pharmaceuticals: MajorHealth Technology The United States Pharmacopeia engages in manufacturing medicines. It offers dietary supplements, and foods. The company is headquartered in Rockville, MD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
St. Joseph's University | College/University | Masters Business Admin | |
Cephalon, Inc.
![]() Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Veridex LLC
![]() Veridex LLC Medical SpecialtiesHealth Technology Part of Kenvue, Inc., Veridex LLC is a company that supplies vitro diagnostic oncology products. The company is based in Raritan, NJ. | Medical Specialties | Sales & Marketing | |
MEDIVATION INC | Pharmaceuticals: Major | Chief Executive Officer | |
UROGEN PHARMA LTD. | Biotechnology | Chief Executive Officer | |
SAGE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
ALLOGENE THERAPEUTICS, INC. | Biotechnology | Director/Board Member |
Statistik
International
Vereinigte Staaten | 31 |
Frankreich | 6 |
Vereinigtes Königreich | 4 |
Belgien | 4 |
Schweiz | 3 |
Sektoral
Health Technology | 31 |
Consumer Services | 6 |
Finance | 5 |
Commercial Services | 4 |
Health Services | 3 |
Operativ
Director/Board Member | 111 |
Corporate Officer/Principal | 55 |
Independent Dir/Board Member | 30 |
Chairman | 22 |
President | 18 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Stephen Evans-Freke | 34 |
Robert Rodin | 28 |
Jean Bizzari | 24 |
Jacques Theurillat | 22 |
Christopher Martin | 18 |
Michael Forer | 18 |
Robert Azelby | 15 |
Elizabeth Barrett | 14 |
Susanne Antonie Schaffert | 13 |
Joseph S. Camardo | 12 |
Jennifer Herron | 12 |
Jose Carmona | 11 |
Peter J. Graham | 8 |
Michael Mulkerrin | 8 |
Robert Schmidt | 6 |
- Börse
- Insiders
- David Gilman
- Unternehmensverbindungen